Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management
- The BioArc Ultra offers economic and environmental sustainability benefits to customers.
- The innovative, eco-friendly refrigeration technology reduces electric power consumption by 70% and storage system footprint.
- The Ultra will be featured at the SLAS 2024 International Conference, with a panel discussion on its savings and sustainability.
- None.
Insights
The introduction of Azenta's BioArc™ Ultra represents a significant advancement in the biorepository sector, with potential implications for operational efficiency and sustainability practices. The product's innovative eco-friendly cooling technology, which leverages natural air instead of traditional refrigerants, aligns with the growing demand for sustainable solutions across industries. This could influence the competitive landscape by setting new benchmarks for environmental responsibility while reducing operational costs.
From a market perspective, the claimed 70% reduction in electricity consumption and storage system footprint could translate into substantial cost savings for Azenta's customers, which might increase the product's adoption rate. Furthermore, the alignment with global carbon emissions reduction goals may enhance Azenta's brand image and market positioning as a leader in sustainable biorepository solutions.
The launch of the BioArc™ Ultra could have a positive impact on Azenta's financial performance. The operational efficiency benefits and cost savings associated with the Ultra are likely to attract new customers and retain existing ones, potentially leading to increased sales revenue. Additionally, the focus on eco-friendly and sustainable technologies may allow Azenta to capitalize on governmental incentives and subsidies aimed at reducing carbon footprints, further improving the company's financial outlook.
Investors should monitor Azenta's sales and earnings reports in subsequent quarters to assess the market's reception of the Ultra and the impact on the company's financials. It's also important to consider the research and development costs associated with bringing such an innovative product to market, as well as the potential for intellectual property rights to provide a competitive moat.
The Ultra's zero ozone depletion potential (ODP) and zero global warming potential (GWP) are critical elements that reflect Azenta's commitment to environmental sustainability. These features are particularly relevant in light of increasing regulatory pressures and public awareness regarding climate change and ecological impact. By offering a solution that addresses these concerns, Azenta not only contributes to the global sustainability efforts but also appeals to a segment of the market that prioritizes eco-friendly operations.
Understanding the long-term implications of such technologies is essential. The shift towards sustainable practices in sample management could inspire similar innovations in other sectors, potentially leading to a broader transformation in how industries approach environmental sustainability. This underscores the importance of evaluating the lifecycle environmental benefits of new technologies, beyond immediate operational savings.
The Ultra features a breakthrough eco-friendly cooling system utilizing natural air rather than manufactured, ozone-depleting refrigerants, enabling a zero ozone depletion potential (ODP) and zero global warming potential (GWP), two factors that are key to sustainability needs and initiatives within life sciences industries and applications. The innovative, eco-friendly, refrigeration technology also reduces electric power consumption by
"We are proud to launch the BioArc Ultra, a breakthrough solution that offers countless economic and environmental sustainability benefits to our customers across the sample management landscape," stated Dean Montano, Senior Product Manager for Azenta's Automated Storage Solutions. "We have always maintained the belief that automation is the key to best-in-class sample management in terms of sample security, collection visibility, and efficient operations, and the Ultra takes our portfolio of offerings in this category to the next frontier."
The Ultra is now available for order and will be featured at the Azenta exhibit booth #909 at Society for Laboratory Automation and Screening (SLAS) 2024 International Conference, February 3-7 in
For more information visit the BioArc Ultra webpage or to schedule a meeting at SLAS, please register here.
"Safe Harbor Statement" under Section 21E of the Securities Exchange Act of 1934
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause results to differ materially from our expectations. They are based on the facts known to management at the time they are made. These forward-looking statements include but are not limited to statements about the expected performance of the BioArc Ultra with respect to energy efficiency, greenhouse gas emissions reductions and footprint reduction capacity. Factors that could cause results to differ from our expectations include the following: the use of the product outside of its intended operation consistent with the product specifications; changes in the design of the product to meet unanticipated customer requirements; and other factors and other risks, including those that we have described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, Current Reports on Form 8-K and our Quarterly Reports on Form 10-Q. As a result, we can provide no assurance that the performance of the BioArc Ultra will not be materially different from those projected. Azenta expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions, or circumstances on which any such statement is based. Azenta undertakes no obligation to update the information contained in this press release.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-launches-the-bioarc-ultra-a-breakthrough-automated-solution-for-efficient-eco-friendly-ultracold-sample-management-302051280.html
SOURCE Azenta
FAQ
What is the name of the innovative ultracold sample management solution launched by Azenta, Inc.?
What are the key operational efficiency benefits of the Ultra?
Where will the launch of the Ultra be featured?
What is the percentage reduction in electric power consumption provided by the Ultra?
Where can more information about the BioArc Ultra be found?
